Oneness Biotech Co., Ltd. (4743.TWO)
TWD 63.0
(-10.0%)
TWD 63.0
(-10.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 86.78 Million TWD | -91.86% |
| 2022 | 1.06 Billion TWD | 1520.24% |
| 2021 | 65.76 Million TWD | 58.07% |
| 2020 | 41.6 Million TWD | 208.76% |
| 2019 | 13.47 Million TWD | -28.54% |
| 2018 | 18.85 Million TWD | 628.88% |
| 2017 | 2.58 Million TWD | -54.64% |
| 2016 | 5.7 Million TWD | -27.27% |
| 2015 | 7.84 Million TWD | 43.11% |
| 2014 | 5.47 Million TWD | 18.88% |
| 2013 | 4.6 Million TWD | -46.39% |
| 2012 | 8.59 Million TWD | 131.41% |
| 2011 | 3.71 Million TWD | -93.71% |
| 2010 | 59.09 Million TWD | 3523.11% |
| 2009 | 1.63 Million TWD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 25.81 Million TWD | 0.53% |
| 2024 Q2 | 30.78 Million TWD | 19.26% |
| 2023 Q1 | 22.18 Million TWD | 50.16% |
| 2023 Q2 | 19.89 Million TWD | -10.34% |
| 2023 FY | 86.78 Million TWD | -91.86% |
| 2023 Q3 | 19.02 Million TWD | -4.34% |
| 2023 Q4 | 25.67 Million TWD | 34.92% |
| 2022 Q3 | 13.85 Million TWD | -98.64% |
| 2022 Q1 | 20.08 Million TWD | 10.26% |
| 2022 FY | 1.06 Billion TWD | 1520.24% |
| 2022 Q4 | 14.77 Million TWD | 6.66% |
| 2022 Q2 | 1.01 Billion TWD | 4963.2% |
| 2021 Q2 | 12.72 Million TWD | 15.92% |
| 2021 Q3 | 23.84 Million TWD | 87.3% |
| 2021 FY | 65.76 Million TWD | 58.07% |
| 2021 Q4 | 18.21 Million TWD | -23.6% |
| 2021 Q1 | 10.98 Million TWD | 130.84% |
| 2020 Q2 | 31.66 Million TWD | 875.81% |
| 2020 FY | 41.6 Million TWD | 208.76% |
| 2020 Q4 | 4.75 Million TWD | 145.46% |
| 2020 Q1 | 3.24 Million TWD | 36.63% |
| 2020 Q3 | 1.93 Million TWD | -93.88% |
| 2019 Q2 | 2.18 Million TWD | -47.75% |
| 2019 Q1 | 4.18 Million TWD | -10.25% |
| 2019 Q4 | 2.37 Million TWD | -49.79% |
| 2019 FY | 13.47 Million TWD | -28.54% |
| 2019 Q3 | 4.73 Million TWD | 116.38% |
| 2018 Q4 | 4.66 Million TWD | 12.53% |
| 2018 Q1 | 7.34 Million TWD | 568.52% |
| 2018 Q2 | 2.7 Million TWD | -63.2% |
| 2018 Q3 | 4.14 Million TWD | 53.22% |
| 2018 FY | 18.85 Million TWD | 628.88% |
| 2017 Q2 | 602 Thousand TWD | 44.71% |
| 2017 FY | 2.58 Million TWD | -54.64% |
| 2017 Q4 | 1.09 Million TWD | 133.83% |
| 2017 Q3 | 470 Thousand TWD | -21.93% |
| 2017 Q1 | 416 Thousand TWD | -68.39% |
| 2016 Q4 | 1.31 Million TWD | -28.94% |
| 2016 Q3 | 1.85 Million TWD | 58.83% |
| 2016 Q2 | 1.16 Million TWD | -14.83% |
| 2016 Q1 | 1.36 Million TWD | 10.58% |
| 2016 FY | 5.7 Million TWD | -27.27% |
| 2015 Q3 | 1.67 Million TWD | -62.09% |
| 2015 Q2 | 4.41 Million TWD | 753.58% |
| 2015 Q1 | 517 Thousand TWD | -40.71% |
| 2015 FY | 7.84 Million TWD | 43.11% |
| 2015 Q4 | 1.23 Million TWD | -26.0% |
| 2014 Q4 | 872 Thousand TWD | -60.83% |
| 2014 FY | 5.47 Million TWD | 18.88% |
| 2014 Q3 | 2.22 Million TWD | 41.24% |
| 2014 Q2 | 1.57 Million TWD | 95.78% |
| 2014 Q1 | 805 Thousand TWD | 42.48% |
| 2013 Q3 | 753 Thousand TWD | -59.65% |
| 2013 Q4 | 565 Thousand TWD | -24.97% |
| 2013 FY | 4.6 Million TWD | -46.39% |
| 2013 Q2 | 1.86 Million TWD | 30.95% |
| 2013 Q1 | 1.42 Million TWD | -54.05% |
| 2012 Q3 | 2.75 Million TWD | 0.29% |
| 2012 Q4 | 3.1 Million TWD | 12.72% |
| 2012 Q1 | 2000.00 TWD | -99.95% |
| 2012 FY | 8.59 Million TWD | 131.41% |
| 2012 Q2 | 2.74 Million TWD | 137050.0% |
| 2011 FY | 3.71 Million TWD | -93.71% |
| 2011 Q1 | 2000.00 TWD | -99.99% |
| 2011 Q2 | - TWD | -100.0% |
| 2011 Q3 | - TWD | 0.0% |
| 2011 Q4 | 3.71 Million TWD | 0.0% |
| 2010 Q2 | 6.38 Million TWD | 9428.36% |
| 2010 FY | 59.09 Million TWD | 3523.11% |
| 2010 Q4 | 33.29 Million TWD | 72.05% |
| 2010 Q1 | 67 Thousand TWD | 0.0% |
| 2010 Q3 | 19.35 Million TWD | 203.1% |
| 2009 FY | 1.63 Million TWD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -11820.742% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 92.215% |
| Level Biotechnology Inc. | 660.61 Million TWD | 86.863% |
| Sagittarius Life Science Corp | 440.46 Million TWD | 80.297% |
| NeoCore Technology Co., Ltd. | 64.72 Million TWD | -34.071% |
| TaiMed Biologics Inc. | 491.77 Million TWD | 82.353% |
| GlycoNex Incorporation | 2.54 Million TWD | -3313.965% |
| VBI | 55.85 Million TWD | -55.378% |
| GeneReach Biotechnology Corp. | 225.46 Million TWD | 61.508% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 72.536% |
| SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | -329.704% |
| Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 78.093% |
| Visgeneer Inc. | 147.99 Million TWD | 41.36% |
| Mycenax Biotech Inc. | 652.62 Million TWD | 86.702% |
| Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 94.862% |
| G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 52.171% |
| Neith Corporation | 39.9 Million TWD | -117.485% |
| Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 77.726% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -281.598% |
| Enimmune corporation | 43.49 Million TWD | -99.529% |
| TaiRx, Inc. | 5.08 Million TWD | -1607.654% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| EirGenix Inc. | 1.02 Billion TWD | 91.514% |
| BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 67.217% |
| Sunny Pharmtech Inc. | 428.82 Million TWD | 79.763% |
| Lin BioScience, Inc. | - TWD | -Infinity% |
| BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | 21.04% |
| Feng Chi Biotech Corp. | 180.57 Million TWD | 51.942% |
| Bio Preventive Medicine Corp. | 1.2 Million TWD | -7084.023% |
| Lukas Biomedical Inc. | 231.83 Million TWD | 62.567% |
| RBC Bioscience Corporation | 172.46 Million TWD | 49.681% |
| BiOptic Inc. | 228.26 Million TWD | 61.982% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -96325.556% |
| Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | -811.203% |
| Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -1689.34% |
| Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 95.276% |
| Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
| NaviFUS Corp. | 22.48 Million TWD | -286.028% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 38.529% |
| Sinew Pharma Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -10680.497% |
| Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 89.159% |
| Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | -52.476% |
| AP Biosciences Inc | 32.25 Million TWD | -169.07% |
| Medigen Biotechnology Corp. | 1.15 Billion TWD | 92.504% |
| 3D Global Biotech Inc. | 20.63 Million TWD | -320.603% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 72.406% |
| Intech Biopharm Corporation | 25.84 Million TWD | -235.757% |
| Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
| TWi Biotechnology, Inc. | - TWD | -Infinity% |
| Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 88.557% |
| TCI GENE Inc. | 333.85 Million TWD | 74.006% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -482027.778% |
| Senhwa Biosciences, Inc. | 1 Million TWD | -8578.3% |
| Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | -1.536% |
| NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 45.809% |
| PharmaEngine, Inc. | 767.66 Million TWD | 88.695% |
| Savior Lifetec Corporation | 1.05 Billion TWD | 91.737% |
| TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 29.521% |
| OBI Pharma, Inc. | 41.54 Million TWD | -108.869% |
| Meribank Biotech Co., Ltd | 234.34 Million TWD | 62.967% |
| Acepodia, Inc. | 16.59 Million TWD | -423.01% |
| Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | -122.909% |